These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3963183)

  • 1. Circulating forms of somatostatinlike immunoreactivity in human plasma.
    Shoelson SE; Polonsky KS; Nakabayashi T; Jaspan JB; Tager HS
    Am J Physiol; 1986 Apr; 250(4 Pt 1):E428-34. PubMed ID: 3963183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma somatostatin 28 increases in response to feeding in man.
    Polonsky KS; Shoelson SE; Docherty HM
    J Clin Invest; 1983 May; 71(5):1514-8. PubMed ID: 6133883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersomatostatinemia in chronic renal failure.
    Wasada T; Inoue K; Fujimi S; Sako Y; Hisatomi A; Ibayashi H
    Endocrinol Jpn; 1987 Apr; 34(2):251-6. PubMed ID: 2887424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-like immunoreactivity (SLI) in pancreatic and intestinal tissues of the duck. A possible origin for the portal circulating SLI.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    Horm Metab Res; 1985 Nov; 17(11):566-71. PubMed ID: 2867025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the presence of somatostatin 28 in plasma.
    Shoelson S; Polonsky K; Docherty H; Jaspan J; Rubenstein A
    Diabetes; 1982 May; 31(5 Pt 1):474-7. PubMed ID: 6130021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin-like immunoreactivity in mammalian thyroid glands: contents and partial characterization.
    Oyama H; Kameda Y; Endoh M; Nagase Y; Matsuki M; Kakita K; Tenku A; Nishida S; Horino M
    Endocrinology; 1984 Mar; 114(3):1028-32. PubMed ID: 6141931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of plasma somatostatin-like immunoreactivity (SLI) to a 75 g oral glucose tolerance test in normal subjects and patients with impaired glucose tolerance.
    Itoh M; Hirooka Y; Nihei N
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):468-74. PubMed ID: 6140806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement, characterization, and source of somatostatin-like immunoreactivity in human amniotic fluid.
    Fitz-Patrick D; Patel YC
    J Clin Invest; 1979 Sep; 64(3):737-42. PubMed ID: 468988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential neural regulation of circulating somatostatin-14 and somatostatin-28 in conscious dogs.
    Greenberg GR
    Am J Physiol; 1993 May; 264(5 Pt 1):G902-9. PubMed ID: 8098911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing of synthetic somatostatin-28 and a related endogenous rat hypothalamic somatostatin-like molecule by hypothalamic enzymes.
    Zingg HH; Patel YC
    Life Sci; 1982 Feb; 30(6):525-33. PubMed ID: 6122155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral plasma concentrations of somatostatin-like immunoreactivity in newborns and infants.
    Koshimizu T; Ohyama Y; Yokota Y; Ohtsuka K
    J Clin Endocrinol Metab; 1985 Jul; 61(1):78-82. PubMed ID: 3998074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of somatostatin like immunoreactivity (SLI) in extracts of porcine, canine and human pancreas.
    Newgard CB; Holst JJ
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):564-72. PubMed ID: 6118002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
    Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
    Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of somatostatinlike immunoreactivity from canine fundic mucosal cells in primary culture.
    Soll AH; Yamada T; Park J; Thomas LP
    Am J Physiol; 1984 Nov; 247(5 Pt 1):G558-66. PubMed ID: 6149697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin type A receptors mediate intestinal fat-induced inhibition of acid secretion through somatostatin-14 in dogs.
    Fung L; Pokol-Daniel S; Greenberg GR
    Endocrinology; 1994 Jun; 134(6):2376-82. PubMed ID: 7910794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma.
    Yandle TG; Espiner EA; Nicholls MG; Duff H
    J Clin Endocrinol Metab; 1986 Jul; 63(1):72-9. PubMed ID: 2940257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog.
    Polonsky KS; Jaspan JB; Berelowitz M; Emmanouel DS; Dhorajiwala J
    J Clin Invest; 1981 Nov; 68(5):1149-57. PubMed ID: 6117570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture.
    Zingg HH; Patel YC
    J Clin Invest; 1982 Nov; 70(5):1101-9. PubMed ID: 7130395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for somatostatin precursors in human stomach, placenta, and amniotic fluid.
    Fitz-Patrick D; Patel YC
    J Clin Endocrinol Metab; 1981 Aug; 53(2):372-6. PubMed ID: 6114109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
    Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
    Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.